Brandish; Philip E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brandish; Philip E..The latest application filed is for "antibodies specific for immunoglobulin-like transcript 3 (ilt3) and uses thereof".

Company Profile

4.4.16

Brandish; Philip E. - Needham MA
Brandish; Philip E. - Boston MA US
Brandish; Philip E. - North Wales PA
Brandish, Philip E. - Blue Bell PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies Specific For Immunoglobulin-like Transcript 3 (ilt3) And Uses Thereof App 20220033497 - Meehl; Michael A. ; et al.	2022-02-03
Antibodies Specific For Immunoglobulin-like Transcript 3 (ilt3) And Uses Thereof App 20220025042 - Meehl; Michael A. ; et al.	2022-01-27
Antibodies Specific For Immunoglobulin-like Transcript 3 (ilt3) And Uses Thereof App 20220025043 - Meehl; Michael A. ; et al.	2022-01-27
Antibodies Specific For Immunoglobulin-like Transcript 3 (ilt3) And Uses Thereof App 20220010010 - Meehl; Michael A. ; et al.	2022-01-13
Antibodies Specific For Immunoglobulin-like Transcript 3 (ilt3) And Uses Thereof App 20220010011 - Meehl; Michael A. ; et al.	2022-01-13
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof Grant 11,111,297 - Meehl , et al. September 7, 2	2021-09-07
Phosphonate Linkers And Their Use To Facilitate Cellular Retention Of Compounds App 20210015930 - Garbaccio; Robert M. ; et al.	2021-01-21
Phosphonate linkers and their use to facilitate cellular retention of compounds Grant 10,869,929 - Garbaccio , et al. December 22, 2	2020-12-22
Antibody Drug Conjugate For Anti-inflammatory Applications App 20200164085 - Brandish; Philip E. ; et al.	2020-05-28
Phosphate based linkers for intracellular delivery of drug conjugates Grant 10,550,190 - Garbaccio , et al. Fe	2020-02-04
Antibodies Specific For Immunoglobulin-like Transcript 3 (ilt3) And Uses Thereof App 20190153093 - MEEHL; MICHAEL A. ; et al.	2019-05-23
Phosponate Linkers And Their Use To Facilitate Cellular Retention Of Compounds App 20190030171 - Garbaccio; Robert M. ; et al.	2019-01-31
Phosphate Based Linkers For Intracellular Delivery Of Drug Conjugates App 20170182181 - Garbaccio; Robert M. ; et al.	2017-06-29
Mineralocorticoid receptor modulators Grant 8,063,090 - Brandish , et al. November 22, 2	2011-11-22
3-Animopyraolines for Treatment of Neurodegenerative and Psychiatric Diseases App 20110003862 - Brandish; Philip E. ; et al.	2011-01-06
Mineralocorticoid Receptor Modulators App 20100261765 - Brandish; Philip E. ; et al.	2010-10-14
Mineralocorticoid Receptor Modulators App 20100069452 - Brandish; Philip E. ; et al.	2010-03-18
Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase Inhibitors App 20090306169 - Brandish; Philip E. ; et al.	2009-12-10
Assays for inositol phosphates App 20040180394 - Brandish, Philip E. ; et al.	2004-09-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.